Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Crizanlizumab for the prevention of recurrent vaso-occlusive crises in children with sickle cell disease Crizanlizumab (SEG101; Adakveo) Sickle cell disease (SCD) Haematology 2022 View  |  Download
Crizanlizumab (formerly SelG1) for Sickle Cell Disease Crizanlizumab (SEG101; Adakveo) Sickle cell anaemia Haematology 2017 View  |  Download
Crenolanib for Advanced or Metastatic Gastrointestinal Stromal Tumours (GISTs) with the D842V Mutation in the PDGFRA Gene Crenolanib (CP-868; CP-868596) Gastrointestinal stromal tumour (GIST) Gastrointestinal Cancer 2018 View  |  Download
Concizumab for treating haemophilia A and haemophilia B Concizumab (NN-7415; mAb-2021; NNC-0172-0000-2021; NNC-0172-2021; NNC-172-2021) Haemophilia A , Haemophilia B Haematology 2022 View  |  Download
Conbercept for neovascular age-related macular degeneration Conbercept (KH902) Age-related macular degeneration (AMD) Ophthalmology 2021 View  |  Download
Cobolimab with dostarlimab and docetaxel for advanced non-small-cell lung cancer after anti-PD-L1 therapy and chemotherapy Cobolimab , Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Dostarlimab (TSR-042; Jemperli) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Clostridium botulinum type A toxin-haemagglutinin complex (Dysport) for urinary incontinence Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Neurogenic detrusor overactivity , Urinary incontinence Neurology , Urology 2021 View  |  Download
Clostridium botulinum Type A toxin (Dysport) for Spasmodic torticollis Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Spasmodic torticollis Musculoskeletal System , Neurology 2017 View  |  Download
Clostridium botulinum neurotoxin A (Xeomin) for lower limb spasticity due to cerebral palsy – first line Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Lower limb spasticity Musculoskeletal System , Neurology 2017 View  |  Download
Clobetasol propionate for postoperative pain and inflammation associated with cataract surgery Clobetasol propionate ophthalmic nanoemulsion (SVT-15473) Post-operative inflammation , Post-operative pain Immunology , Pain Relief 2020 View  |  Download
1 2 92 93 94 95 96 117 118
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications